Latest News and Press Releases
Want to stay updated on the latest news?
-
THE WOODLANDS, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor of two...
-
Tuscaloosa, AL and Oakville, ON, March 25, 2024 (GLOBE NEWSWIRE) -- Given the offseason Jalen Milroe has faced – coaching change and all, there’s more than enough motivation to “let all the...
-
NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA). The...
-
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA). The class...
-
NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA). The...
-
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA). The class...
-
NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA). The class...
-
Fort Collins, Colorado, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The CBD Nutraceuticals Market size was valued at USD 3.8 Billion in 2022 and is anticipated to reach USD 16.9 Billion by 2032 at a CAGR of...
-
Smithfield, RI, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Registration is now open for Bryant University’s 27th Women's Summit®, which returns to the Smithfield campus on Thursday, March 14 with a lineup of...
-
NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA). The class...